Ditchcarbon
  • Customers
  1. Organizations
  2. Hangzhou Tigermed
Public Profile
Medical Device Manufacturing
CN
updated 22 minutes ago

Hangzhou Tigermed

Company website

Hangzhou Tigermed Consulting Co., Ltd., commonly known as Tigermed, is a leading clinical research organisation headquartered in Hangzhou, China. Founded in 2004, the company has established a strong presence across Asia, Europe, and North America, providing comprehensive services in the pharmaceutical and biotechnology sectors. Tigermed specialises in clinical trial management, regulatory affairs, and data management, offering unique solutions that streamline the drug development process. With a commitment to quality and innovation, the company has achieved significant milestones, including numerous successful trials for global clients. Recognised for its expertise and reliability, Tigermed holds a prominent position in the industry, contributing to advancements in healthcare and supporting the development of new therapies. Its dedication to excellence has earned it a reputation as a trusted partner in clinical research.

DitchCarbon Score

How does Hangzhou Tigermed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

39

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Hangzhou Tigermed's score of 39 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Hangzhou Tigermed's reported carbon emissions

In 2024, Hangzhou Tigermed Consulting Co., Ltd. reported total carbon emissions of approximately 13,060,860 kg CO2e, with Scope 1 emissions at about 116,820 kg CO2e and Scope 2 emissions at approximately 12,944,040 kg CO2e. This represents a decrease from 2023, where total emissions were about 13,850,210 kg CO2e, with Scope 1 at approximately 118,730 kg CO2e and Scope 2 at around 13,731,490 kg CO2e. The company has set ambitious reduction targets, aiming for a 15% reduction in both Scope 1 and Scope 2 emissions by 2025 compared to 2019 levels. Additionally, they have committed to a 42% reduction in absolute Scope 1 and 2 GHG emissions by 2030 from a 2023 baseline, alongside a 25% reduction in Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Hangzhou Tigermed's emissions data is not cascaded from any parent organization, indicating that the reported figures and commitments are independently sourced. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in China.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20172018201920202021202220232024
Scope 1
63,180,000
00,000,000
00,000,000
00,000
00,000
000,000
000,000
000,000
Scope 2
1,037,878,000
0,000,000,000
000,000,000
000,000
0,000,000
0,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hangzhou Tigermed's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hangzhou Tigermed is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hangzhou Tigermed is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Wuxi Apptec

CN
•
Research and development services (73)
Updated 12 days ago

PPD, Inc.

US
•
Research and development services (73)
Updated 22 days ago

Labcorp

US
•
Health and social work services (85)
Updated about 19 hours ago

Fountain Medical Development Ltd

CN
Updated 22 days ago

Boji Pharmaceutical Group

CN
Updated 22 days ago

Parexel

US
•
Research and development services (73)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250815.2
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy